Pamela Palmer, MD, PhD, envisioned a different way to treat moderate-to-severe acute pain. Learn what inspired the AcelRx cofounder to develop a novel noninvasive technology.

Read the story »

COVID-19 Update

If your hospital is facing an IV opioid shortage during the COVID-19 pandemic, AcelRx may be able to provide assistance. Please read the letter from Dr. Palmer to learn more about this option.

Read the letter »

About AcelRx

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings.

FDA-approved

Please see DSUVIA Important Safety Information, including BOXED WARNING, and full Prescribing Information.

visit dsuvia.com »

proprietary sublingual technology

DSUVIA^® was developed using this proprietary sublingual technology.

Learn More